- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
6185
HKG
Week ended 21 Aug 2026
Weekly Investor Report
CanSino Biologics Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
29.48 HKD
19.4%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 1.9% above the Trend Line and sits at 24.4% of its 52-week range. The latest completed week returned 19.4%, after a 26.1% four-week move. The latest news-sentiment score is 50/100.
Setup score
42
out of 100
Latest Close
29.48 HKD
21 Aug 2026
1W Return
19.4%
latest completed week
4W Return
26.1%
short-term follow-through
12W Return
14.2%
quarterly tape
Trend Breadth
25.0%
13 of 52 weeks active
Volume Ratio
9.5x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Next-week expectancy is negative at 44.64% based on similar historical setup states.
- Activity pressure is weak, so confirmation is not yet broad enough.
- The share remains more than 20% below its 52-week high.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
19.4%
Latest completed week; four-week move 26.1%.
Indicator stack
14/68
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Buy
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 44.64%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
4 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 1.9% above the Trend Line and sits at 24.4% of its 52-week range. The latest completed week returned 19.4%, after a 26.1% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 9.5x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
14 Aug
21 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0612-week average 0.06
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure1/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.06Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 26.1% over four weeks, 14.2% over 12 weeks, and -43.1% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year13
Trend breadth25.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.40Latest activity-pressure read.
Pressure change138.4%Four-week change in activity pressure.
Leadership-16.37Latest relative-leadership reading.
RS change52.5%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 4 relevant articles.
0 positive · 4 neutral · 0 negativePatient CapitalFresh
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Fresh buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-47.9%Distance below the 52-week high.
13-week volatility8.2%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
27 Feb
27 Mar
24 Apr
22 May
19 Jun
17 Jul
21 Aug
Weeks higher8 of 2618 weeks finished lower.
Best week+19.4%Week of 21 Aug.
Worst week-10.5%Week of 1 May.
Latest week+19.4%Week of 21 Aug.
Shape of recent returns
Strong gains6
Modest gains2
Flat weeks0
Modest losses11
Sharp losses7
Recent vol8.2%13-week weekly-return volatility.
Base vol6.5%52-week weekly-return volatility.
Up/down split16/36Count of positive and negative weeks in the 52-week window.
Average skew6.8% / -4.3%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorHK Healthcare
4-week rank13 / 100
Group average7.4%
Trend breadth17.0%
Trend17.0%active weekly trend signals
MD60.0%positive activity pressure
RS20.0%positive relative leadership
Four-week leaders
IndustryHK Drug Manufacturers - Specialty & Generic
4-week rank1 / 50
Group average-0.4%
Trend breadth8.0%
Trend8.0%active weekly trend signals
MD56.0%positive activity pressure
RS14.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape32/100
Trend, activity pressure, participation, and risk combine to a 32/100 tape read.
Indicator analysis11/100Latest 12-week confirmation: trend 0/12, activity pressure 1/12, relative leadership 0/12.
Activity pressure 0.06; No reversal markers Next-Week ExpectancyNegative 44.64%Next-week expectancy is negative with a 44.64% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalFreshActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Fresh buy signal Sentiment50/100Weighted news tone is neutral across 4 relevant articles.
CanSino Biologics Publishes Unaudited Interim Results for First Half of 2026 Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 21 Aug 2026 | 29.48 HKD | 19.4% | 28.94 HKD | 29.33 HKD | 0.40 | -16.37 | 67.8M | Off |
| 14 Aug 2026 | 24.70 HKD | -0.2% | 29.20 HKD | 29.30 HKD | -0.19 | -28.37 | 5.0M | Off |
| 7 Aug 2026 | 24.74 HKD | 6.3% | 29.62 HKD | 29.30 HKD | -0.56 | -30.77 | 3.2M | Off |
| 31 Jul 2026 | 23.28 HKD | -0.4% | 30.06 HKD | 29.32 HKD | -0.93 | -36.30 | 2.0M | Off |
| 24 Jul 2026 | 23.38 HKD | 0.8% | 30.45 HKD | 29.35 HKD | -1.05 | -34.46 | 2.3M | Off |
| 17 Jul 2026 | 23.20 HKD | -0.9% | 30.88 HKD | 29.40 HKD | -1.28 | -34.55 | 898.0K | Off |
| 10 Jul 2026 | 23.42 HKD | -3.8% | 31.34 HKD | 29.41 HKD | -1.49 | -33.47 | 666.2K | Off |
| 3 Jul 2026 | 24.34 HKD | 16.1% | 31.82 HKD | 29.44 HKD | -1.69 | -28.95 | 1.3M | Off |
| 26 Jun 2026 | 20.96 HKD | -6.6% | 32.29 HKD | 29.44 HKD | -1.91 | -37.34 | 731.6K | Off |
| 19 Jun 2026 | 22.44 HKD | -3.2% | 32.91 HKD | 29.47 HKD | -1.79 | -36.84 | 2.3M | Off |
| 12 Jun 2026 | 23.18 HKD | -3.2% | 33.48 HKD | 29.48 HKD | -1.49 | -37.30 | 658.4K | Off |
| 5 Jun 2026 | 23.94 HKD | -7.3% | 34.24 HKD | 29.53 HKD | -1.12 | -36.31 | 1.1M | Off |
| 29 May 2026 | 25.82 HKD | -8.0% | 34.90 HKD | 29.56 HKD | -0.66 | -32.34 | 5.2M | Off |
| 22 May 2026 | 28.06 HKD | -0.6% | 35.59 HKD | 29.58 HKD | -0.53 | -28.07 | 6.9M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.